Legislature(2015 - 2016)HOUSE FINANCE 519
03/29/2016 05:00 PM House FINANCE
| Audio | Topic |
|---|---|
| Start | |
| SB74 | |
| Public Testiomony | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| += | SB 74 | TELECONFERENCED | |
| + | TELECONFERENCED |
HOUSE FINANCE COMMITTEE
March 29, 2016
5:08 p.m.
5:08:11 PM
CALL TO ORDER
Co-Chair Thompson called the House Finance Committee
meeting to order at 5:08 p.m.
MEMBERS PRESENT
Representative Mark Neuman, Co-Chair
Representative Steve Thompson, Co-Chair
Representative Dan Saddler, Vice-Chair
Representative Bryce Edgmon
Representative Les Gara
Representative Lynn Gattis
Representative David Guttenberg
Representative Scott Kawasaki
Representative Cathy Munoz
Representative Lance Pruitt
Representative Tammie Wilson
MEMBERS ABSENT
None
ALSO PRESENT
Becky Hultberg, President and CEO, Alaska State Hospital
and Nursing Home Association, Juneau.
PRESENT VIA TELECONFERENCE
Robin Minard, Mat-Su Health Foundation, Wasilla; Daniel
Nelson, Pharmacist and Member Alaska Pharmacists
Association, Fairbanks; Margaret Soden, Retired Pharmacist,
and Member Alaska Pharmacists Association, Fairbanks; Nancy
Merriman, Executive Director, Alaska Primary Care
Association, Juneau; Tara Ruffner, Alaska Pharmacists
Association, Kenai; Shannon Hilton, Alaska Nurse
Practitioner Association and Advanced Nurse Practitioner
Alliance, Anchorage; Lis Houchen, Northwest Regional
Director, National Association of Chain Drugstores,
Brinnon, Washington; Dirk White, Pharmacist, Sitka; Timothy
Noah Laufer, MD, Anchorage; Dick Hubbs, COO, Geneva Woods
Pharmacy, Anchorage; Ilona Farr, Family Practice Physician,
Anchorage; Dave Donley, Hope Community Resources,
Anchorage; Ross Bieling, Self, Anchorage; Michael Bailey,
Vice President, Alaska Association on Development
Disabilities, Anchorage; Judy Eledge, Self, Anchorage.
SUMMARY
CSSB 74(FIN) am
MEDICAID REFORM;TELEMEDICINE;DRUG DATABASE
CSSB 74(FIN) am was HEARD and HELD in committee
for further consideration.
CS FOR SENATE BILL NO. 74(FIN) am
"An Act relating to diagnosis, treatment, and
prescription of drugs without a physical examination
by a physician; relating to the delivery of services
by a licensed professional counselor, marriage and
family therapist, psychologist, psychological
associate, and social worker by audio, video, or data
communications; relating to the duties of the State
Medical Board; relating to limitations of actions;
establishing the Alaska Medical Assistance False Claim
and Reporting Act; relating to medical assistance
programs administered by the Department of Health and
Social Services; relating to the controlled substance
prescription database; relating to the duties of the
Board of Pharmacy; relating to the duties of the
Department of Commerce, Community, and Economic
Development; relating to accounting for program
receipts; relating to public record status of records
related to the Alaska Medical Assistance False Claim
and Reporting Act; establishing a telemedicine
business registry; relating to competitive bidding for
medical assistance products and services; relating to
verification of eligibility for public assistance
programs administered by the Department of Health and
Social Services; relating to annual audits of state
medical assistance providers; relating to reporting
overpayments of medical assistance payments;
establishing authority to assess civil penalties for
violations of medical assistance program requirements;
relating to seizure and forfeiture of property for
medical assistance fraud; relating to the duties of
the Department of Health and Social Services;
establishing medical assistance demonstration
projects; relating to Alaska Pioneers' Homes and
Alaska Veterans' Homes; relating to the duties of the
Department of Administration; relating to the Alaska
Mental Health Trust Authority; relating to feasibility
studies for the provision of specified state services;
amending Rules 4, 5, 7, 12, 24, 26, 27, 41, 77, 79,
82, and 89, Alaska Rules of Civil Procedure, and Rule
37, Alaska Rules of Criminal Procedure; and providing
for an effective date."
5:08:38 PM
Co-Chair Thompson discussed the meeting agenda.
^PUBLIC TESTIOMONY
5:08:55 PM
ROBIN MINARD, MAT-SU HEALTH FOUNDATION, WASILLA (via
teleconference), testified in support of SB 74. She
communicated that the Mat-Su Health Foundation shared
ownership in Mat-Su Regional Medical Center and invested
its profits back into the community in order to improve the
health and wellness of Alaskans in the region. She detailed
that the foundation co-owned a hospital to care for people
when illness and injury was not prevented; it also made
grants to create a healthier population. The foundation had
supported Medicaid expansion in order to increase access to
behavioral health and primary care for more Alaskans;
however, they had supported expansion only if it was
coupled with reform. She spoke to the need for Medicaid
reform measures. She relayed that expansion had improved
access to care for behavioral health issues and could
prevent costly emergency department visits. Medicaid
expansion and reform could help the foundation provide
better care for individuals, better health for populations,
and lower per capita costs. She stated that Medicaid
expansion and reform could bring more care to more people
at a lower cost. The foundation strongly supported the use
of telemedicine. She highlighted the difficulty of
recruiting and retaining an effective behavioral health
workforce in states with large populations like Alaska. She
pointed to Alaska's lower rates of psychiatrists, substance
abuse counselors, and other. She stressed that Alaska was
designated as federal mental health shortage areas. The
foundation also supported the implementation of stronger
prescription drug monitoring to help battle opioid abuse.
Lastly, the foundation supported the use of case management
services in order to incentivize patient-centered care that
would result in cost savings. The foundation was
particularly interested in case management targeted to high
utilizers of emergency care. In 2013 there were more than
6,000 visits to the local hospital emergency department
with charges of $23 million by patients with behavioral
health needs - the figure did not include $1.6 million for
law enforcement, 911 dispatch, and transportation. She
noted that only a portion of the patients had been on
Medicaid, but the numbers were still significant. There
were 66 super utilizers (someone with more than 10 visits
to the emergency room annually). She reiterated the
foundation's support for the legislation.
5:12:55 PM
DANIEL NELSON, PHARMACIST and MEMBER ALASKA PHARMACISTS
ASSOCIATION, FAIRBANKS (via teleconference), spoke in
support of the legislation with a modification. He believed
that overall SB 74 was a good bill; however, he had some
significant concerns related to prescription drug
monitoring changes. The believed the requirement for
pharmacists to check the database before they dispense a
controlled substance was onerous and unnecessary. He
believed the check was redundant when it had already been
checked by a prescribing physician. He asked for the
language be removed.
5:14:52 PM
MARGARET SODEN, RETIRED PHARMACIST and MEMBER ALASKA
PHARMACISTS ASSOCIATION, FAIRBANKS (via teleconference),
testified in favor of the legislation, but requested
changes to portions. She shared that when she had served on
the Board of Pharmacy they had begun working on the
prescription drug monitoring statutes. She believed the
changes had made a big difference in trying to deter some
of the controlled prescription substance abuse in Alaska.
She had some concerns over some of the proposed changes to
the bill related to prescription drugs. She believed it was
important to allow prescribers and pharmacists to delegate
authority to another person to access the database, but she
believed the delegated authority should only be to licensed
personnel. She did not believe a pharmacist should have to
check the database each time they received a prescription
for a controlled substance - the physician or prescriber
should have already checked. She reasoned that pharmacists
could always check the database if they had concerns with a
patient presenting a prescription. She did not believe the
emergency room should be exempt from checking the database.
She explained that often "doctor shoppers" went to the
emergency room to get additional prescriptions for
controlled substances. She reiterated her support for the
legislation with minor changes.
5:18:34 PM
BECKY HULTBERG, PRESIDENT and CEO, ALASKA STATE HOSPITAL
AND NURSING HOME ASSOCIATION, JUNEAU, spoke in support of
the legislation. She shared that earlier in the week the
association had provided comments on managed care and the
coordinated care demo project in the bill. She addressed
specific questions from the morning House Finance Committee
meeting related to the emergency room project in Section 31
of the legislation. She communicated that the project was a
collaborative effort between hospitals, emergency
physicians, and the state, with a goal of reducing the
number of unnecessary emergency department visits and
improving patient outcomes. She spoke to the shared savings
component of the bill specifically related to why the state
would share the savings - from the project - with
hospitals. Through the project that the association had
brought forward, hospitals would be spending money to lose
money. She stressed that it was not a great business model;
however, it was the right thing to do. One of the problems
with the healthcare system was that the payment structure
incentivized the wrong things - volume over value. She
explained that the hospitals received revenue from Medicaid
patients who inappropriately use the emergency room. She
furthered that they would lose money in finding less
expensive ways to address the patients behavioral or
physical health issues. The end result would be better care
for the patient and savings to the state. She explained
that hospitals were asking (in the legislation) to have the
opportunity to negotiate shared savings with the state in
order to offset some of the costs the hospitals would
invest in the program. Hospitals would be hiring care
coordinators, dedicating staff time to implement the
project, and their revenue would be reduced from the
specific patients. Currently there was no financial
incentive for the hospitals to do any of the things she had
mentioned, but through shared savings negotiations with the
state, the hospitals could at least recoup the costs they
would spend on implementing the program. She stated it was
a baby step towards paying for value; aligning the
financial interests of providers with those of the state
would help achieve the goal of cost savings and improve
patient care.
Representative Gara relayed that he had a question related
to an emergency room issue.
Co-Chair Thompson noted that the committee would address
the question at a later time.
5:21:47 PM
NANCY MERRIMAN, EXECUTIVE DIRECTOR, ALASKA PRIMARY CARE
ASSOCIATION, JUNEAU (via teleconference), spoke in support
of the bill. She communicated that the association was the
statewide technical assistance and training provider for
community health centers across the state. She provided
additional detail about the association. She urged the
committee to retain the pilot language in Section 31, page
33 of the bill. The association had heard from other
experts and colleagues nationwide that moving from a volume
to value-based payments for providers would protect and
preserve the state's providers (especially the safety net
providers). She explained that the healthcare system in
Alaska had no experience in value-based payments. She
furthered that moving from volume-based - which counted
visits, tests, and procedures for their mode of payment -
to value-based was very different. She believed it was wise
to provide transition time for providers. The association
believed that Accountable Care Organizations (ACO),
demonstrations, and pilots were a good way to give the
opportunity - for the infrastructure and patient engagement
- to change Aetna's practices. She advocated for a
provider-led network would be founded in care coordination
for the high cost, high utilizers of healthcare; the health
centers served those patients on a regular basis. She spoke
to the importance of a data warehouse, data analytics, care
coordination, practice management, understanding workflows,
and other. The association believed the bill's language
would allow for development of the practices, providers,
staff, and patients to go from one end of the spectrum to
the other. The end goal was to allow the smooth transition
to the "triple aim."
5:25:01 PM
TARA RUFFNER, ALASKA PHARMACISTS ASSOCIATION, KENAI (via
teleconference), testified in support of the legislation
with opposition to certain aspects related to the
Prescription Drug Monitoring Program (PDMP). She referred
to Section 18 of the legislation related to pharmacists and
prescribers checking the database for each prescription and
relayed her belief that the requirement was redundant. She
explained that if prescribers were checking before
prescribing, pharmacists had other means of ensuring
patients were not double dipping. She stated that
pharmacists would check any prescription they had concerns
about. Additionally, she strongly felt that only licensed
individuals should have access to the database. She was
concerned that a pharmacist could lose their license for
not checking the database, which she believed was too
stringent and not congruent with the bill's intent.
5:28:01 PM
SHANNON HILTON, ALASKA NURSE PRACTITIONER ASSOCIATION AND
ADVANCED NURSE PRACTITIONER ALLIANCE, ANCHORAGE (via
teleconference), spoke in support of the legislation, but
had comment about the PDMP portion of the legislation. The
association had some concerns about the intended mandate of
the prescription drug monitoring database. The association
felt that the mandate would cause undo financial and time
constraints, while trying to provide the best care possible
in busy clinics. She elaborated that it would impact nurse
practitioners, surgeons, physicians' assistants, and other.
The association recognized that opioid abuse was a multi-
factorial crisis; however, the intention to help combat
over prescribing opioids and early detection was only one
facet of a much larger crisis. Alaska nurse practitioners
had expressed major concern that the system was
consistently inefficient, which led providers to spend
considerable time accessing the database prior to
prescribing. Additionally, the association felt that
punitive sanctions on providers who fail to check the
database prior to filling a prescription was concerning for
a number of reasons. She detailed that evaluations of other
state's PDMP mandates had shown mixed data on the effects
of prescribing habits and mortality outcomes. The
association felt there was the potential for risk of
inappropriate clinical decisions. She stated that mandating
the use of such a program and imposing the sanctions for
failure of use was inconsistent with current guidelines.
Mandates would also impose financial constraint on the
licensing and regulatory boards. She stated that the use of
the PDMP should be performed at the provider's discretion.
She provided an example based on her work experience.
5:31:47 PM
LIS HOUCHEN, NORTHWEST REGIONAL DIRECTOR, NATIONAL
ASSOCIATION OF CHAIN DRUGSTORES, BRINNON, WASHINGTON (via
teleconference), was very supportive of the bill overall;
however, she suggested changes to Sections 14, 15, 18, and
19. She shared that the association had worked closely with
the Alaska Pharmacy Association on the initial passage of
the PDMP. She stated that the PDMP had become a useful tool
in deterring the abuse of legal prescriptions of controlled
substances. She spoke to current pharmacist requirements.
She shared that members of the association were willing to
increase the frequency to within one business day from when
the prescription was sold. She shared that pharmacists
often filled prescriptions that were not picked up;
therefore, the association requested that the language
reflect that reporting be upon when the prescription was
actually picked up; the change would need to be included in
Sections 14 and 19. The biggest concern for association
members was the requirement in Section 18 for a pharmacist
or practitioner to check the database prior to dispensing
or writing a prescription. She asked that prescribers be
required to check the database prior to issuing a
prescription for a controlled substance. She stressed that
pharmacists could only dispense controlled substances.
Checking the database in advance would eliminate confusion
at the pharmacy counter. The additional workload could be
detrimental to the patient waiting for a prescription. She
noted that pharmacists would continue to check the database
based on their professional judgement. She requested the
deletion of a provision that would exempt emergency rooms.
Based on information received from pharmacists, drug
seekers often used emergency rooms (ER) to acquire
controlled substances due to the frenetic nature of the ER.
She requested that pharmacists and practitioners should
only have the ability to delegate access to the database to
licensed individuals, which would allow for disciplinary
action to be taken if the database was accessed
inappropriately. Lastly, she asked that the language
following the word "substance" be deleted from Section 14,
subsection (B)(8). She explained that there had been
significant changes in reporting the pharmacist license
number, which was currently required and unnecessary; the
information was not required in other states. She provided
a summary of concerns.
Co-Chair Thompson asked testifiers to send in their written
remarks.
5:36:51 PM
DIRK WHITE, PHARMACIST, SITKA (via teleconference), agreed
with much of the prior testimony. He was concerned about
the exemption of emergency room doctors from checking the
PDMP. He had witnessed the ER as the main source of drug-
seeking and doctor shopping patients. He reasoned that if
an ER doctor found that a person had been seeking drugs it
would put an end to the situation if the requirement
applied to emergency rooms. He pointed to Section 14 and
believed language related to the date the prescription was
filled and method of payment should be deleted. He thought
the language was unnecessary. He believed delegates should
be licensed and authorized (Section 15); if a person was
not licensed and there was a leak in information he noted
there would be no recourse.
5:40:13 PM
TIMOTHY NOAH LAUFER, MD, ANCHORAGE (via teleconference),
spoke in general support of the bill, with some concerns.
He provided information about his professional background.
He applauded the idea of reforming Medicaid in order to do
a better job of rationally taking care of people. He stated
that primary care doctors were not represented at meetings
that impacted primary care doctors. He spoke to the issue
of controlled substances, which he believed should be
limited to opiates. He stated that all drugs were not the
same and opiates were the problem. He furthered that the
database was very useful, but it would be onerous and
expensive to require its use for all scheduled substances.
He discussed that telemedicine could be a great tool;
however, he provided a scenario that included a well-
trained provider out-of-state making a judgement call about
a patient they had never met. He explained that the
doctor's threshold for sending the patient to the ER would
be substantially lower, which would result in an uptick in
costs and utilization of emergency rooms. He relayed that
cost and utilization increased immediately; he believed
individuals would be going straight to the ER. He discussed
savings that occurred when a person saw their established
primary care doctor.
5:43:41 PM
DICK HUBBS, COO, GENEVA WOODS PHARMACY, ANCHORAGE (via
teleconference), testified in support of Medicaid reform to
improve care and reduce costs for Alaskans. He believed the
bill as proposed included several provisions that would
result in unintended consequences that would severely
impact Alaskans and local businesses. Section 23 proposed
to clarify the department's ability to enter into a
competitively bid contract for durable medical equipment.
He concurred with the clarification, but believed it must
be to a company serving Alaskan patients in all aspects; if
select portions of service were removed and only very low
services remained, local providers would be forced to stop
providing the services. He stressed there was no way the
state could allow high volume items to be outsourced to an
out-of-state provider that was unable to service and repair
the equipment. He supported competition, but not if the
playing field was not equal. The bill proposed a new
provision in Section 17 that would require the adoption of
regulations to design and implement the medical assistance
reform program. He proposed adding language intended to
maximize the benefit that pharmacy initiatives could add to
the program. He suggested adding the following language
"including paid comprehensive medication review, use of
pharmacy transitional services by hospitals, and other
services with the proven record of reducing hospitalization
and readmissions." Section 10 spoke to penalties and legal
fees related to false claims. He believed that penalties
less than actual fraud could result in a significant
negative consequence. The language referred to false claims
in the bill and could easily be misinterpreted. He stated
that in many cases the concept of overpayment due to false
claims was combined with the concept of fraud; however, the
two concepts were different. He recommended removing the
term "false" and limiting the penalties to cases of fraud.
5:47:15 PM
ILONA FARR, FAMILY PRACTICE PHYSICIAN, ANCHORAGE (via
teleconference), relayed that had many concerns about the
bill. She believed the bill included good things, but it
also included provisions that could potentially force many
private practitioners out of business. She shared that she
personally wrote between six and ten prescriptions for
controlled substances per day. She stated that people did
not look to see what controlled substances were before
dealing with the bill because they could include seizure
medication, diabetes medication, cough syrup, and other.
She explained that patients getting an MRI would also now
be included in the database. She stated that the new
provision would cost her about an hour per day and would
cost her practice approximately $125,000 annually. She
stressed that it could be a negative impact of $100 million
to the private sector. She stated that the current system
worked - she was able to look at the database if she had a
patient she was concerned about. She stated that Schedule 3
and 4 drugs had very low risk of abuse. She had looked at
studies on preventing drug abuse - in 2014 less than 1
percent of drug abuse cases were related to prescription
abuse. She recommended that the provision should be limited
to opiates in quantities of more than 40 pills. She asked
what the database would be used for in the future. She
mentioned the difference between telehealth and
telemedicine. She did not believe there would be continuity
of care under a system of telehealth. She stated that the
physicians treating people would be out-of-state and the
hands-on treatment would be lost. She reiterated her
concern about the impact of the provisions.
5:52:22 PM
DAVE DONLEY, HOPE COMMUNITY RESOURCES, ANCHORAGE (via
teleconference), read from a prepared statement:
Hope community resources supports the state's efforts
toward Medicaid reform and appreciates the work that
has gone into SB 74. We were disappointed to learn
last week that the language contained in the false
claims and reporting act has been submitted for
federal approval months ago, without the opportunity
for public comments and input.
We remain concerned that the current language does not
adequately protect honest providers against liability
for the bad acts of rouge employees and provides
insufficient protections for self-reporting and self-
correction of problems. The vast majority of Medicaid
providers seek to provide quality services and are the
first line of defense against false claims and fraud
against Medicaid.
The senate, instead of addressing some of our specific
suggestions, chose to place a three year sunset on
portions of the Medicaid fraud act section. We are
grateful for that sunset provision but continue to
believe it would be much better to address the
specific concerns prior to passing new law.
We believe we and other providers have asked for very
reasonable safeguards for honest law abiding
providers.
Mr. Donley relayed that Hope Community Resources had
provided three specific suggestions to the committee. The
organization wanted to see provisions protecting self-
reporting within the Medicaid Fraud Act (Section 10 of the
legislation). He recommended the following language on
Section 27, page 23 to be included in Section 3, page 7:
The Department of Health and Social Services may not
assess interest or penalties on an overpayment self-
identified and repaid by a medical assistance provider
under this section.
Mr. Donley stated there had been prior testimony by state
officials that similar language in the bill would apply to
the Fraud Act sections, but how it would work was unclear
because the Fraud Act appeared to stand alone. He believed
the language should be clarified because the safe harbor
was important to encourage providers to self-report and
correct. The organization requested that a more precise
definition of "agent" be used in the definitions section of
the bill. He suggested the following definition:
An agent with apparent authority does not include
someone acting in violation of the policies or
instruction of the principal provider without that
provider's knowledge.
Mr. Donley elaborated that the organization would like some
protection against liability. Lastly, he requested the
addition of language related to the False Claims Act in
Section 10, page 8 of the legislation as follows:
...unless the evidence shows that the agent or
apparent agent acted with intent to deceive the
principal.
Mr. Donley expounded that the suggested language would help
protect the state against "rouge agents" acting on their
own against instructions.
5:56:06 PM
ROSS BIELING, SELF, ANCHORAGE (via teleconference),
reminded the committee that the purpose of the bill was
reform - to save money for the state through process. He
spoke to cost reductions and earlier testimony that
hospitals were spending money to lose money and that there
should be shared savings with the state. He countered that
if hospitals were losing money none of "us" would be here.
He stressed that there was a crisis in the cost of
healthcare in Alaska. He stated that Premera had lost $9
million to $12 million the preceding year and Moda could
not pay its bills. He stated that the crisis was cost
based. He spoke to telehealth. He believed consideration
should be given to tort claims that would flow from the
cost of patients - the issues were difficult to fine tune
but they would happen. He thanked the committee for its
attention to detail in the bill.
5:58:45 PM
MICHAEL BAILEY, VICE PRESIDENT, ALASKA ASSOCIATION ON
DEVELOPMENT DISABILITIES, ANCHORAGE (via teleconference),
provided information about the association. The association
supported the concept of Medicaid reform; however, it was
disappointed to learn that language had been submitted to
the Centers for Medicare and Medicaid Services (CMS) months
earlier without the opportunity for public comment. The
association requested that the public hearing at least
record the concerns of providers. The association supported
the conviction of providers who intentionally commit fraud,
but it was unreasonable to assume from publicized
convictions that all providers were committing fraud. He
stated that providers were the first line of defense
against false claims and fraud; many of the providers were
nationally accredited and had implemented policies designed
to prevent false claims. Some examples included pre-billing
controls and post-billing controls (i.e. external audits
and accreditation reviews). He agreed with earlier
testimony about adding protections for self-reporting. He
stated that the remoteness of Alaska did not allow for the
micromanagement of every field worker; therefore, many
providers had established standard operating procedures
that were required for accreditation compliance; expected
behavior of employees included fraud and false claims
prevention. He supported language to Section 10, page 14
proposed by Mr. Donley - that an agent with an apparent
authority did not include someone acting in violation of
the policies or instruction of the principal provider
without that provider's knowledge. The association also
supported language specifying that there should be some
relief for the provider when rogue employees intended to
deceive the principal.
6:02:09 PM
JUDY ELEDGE, SELF, ANCHORAGE (via teleconference), was
disappointed that the legislature could not locate more
than $30 million to cut in the reform. She shared that she
was on Medicare and had very few services and choices. She
was concerned that someone on Medicaid had the "Cadillac
plan." She believed the bill was an opportunity to look at
some of the services that were offered to people on
Medicaid that were not offered to anyone else. She had paid
into Medicare and was bothered when people received
something they were not paying for - she did not have a
problem with it if the individuals were extremely needy,
disabled, or had children in need; however, she did not
support unique Medicaid services going to people who worked
who may not want to be covered on insurance. She believed
there had been $222 million in optional Medicaid services
in 2014. She recommended looking closely at some of the
optional services offered. She did not believe the options
should all be available when people working and paying into
something else did not receive the benefits.
6:05:01 PM
AT EASE
6:21:59 PM
RECONVENED
Co-Chair Thompson noted that there were no testifiers
present or online. He relayed that he would adjourn the
meeting at 6:30 p.m. if there were no additional
testifiers.
6:22:27 PM
AT EASE
6:30:34 PM
RECONVENED
Co-Chair Thompson relayed that there were no additional
testifiers.
CSSB 74(FIN) am was HEARD and HELD in committee for further
consideration.
Co-Chair Thompson discussed the agenda for the following
day.
ADJOURNMENT
6:31:40 PM
The meeting was adjourned at 6:31 p.m.
| Document Name | Date/Time | Subjects |
|---|---|---|
| SB 74 Testimony.pdf |
HFIN 3/29/2016 5:00:00 PM |
SB 74 |
| SB 74 RMadison Testimony.pdf |
HFIN 3/29/2016 5:00:00 PM |
SB 74 |
| SB 74 Testimony provided by Thomas Behan- District 2.pdf |
HFIN 3/29/2016 5:00:00 PM |
SB 74 |
| SB 74 Dr. Farr Testimony pt 2.pdf |
HFIN 3/29/2016 5:00:00 PM |
SB 74 |
| SB 74 Dr. Farr Testimony pt 1.pdf |
HFIN 3/29/2016 5:00:00 PM |
SB 74 |
| SB 74 TESTIMONY OF DAVE DONLEY REPRESENTING HOPE COMMUNITY RESOURCES.pdf |
HFIN 3/29/2016 5:00:00 PM |
SB 74 |